A study has investigated the response from seniors with high risk of Alzheimer’s when told that their brain scans display an ‘elevated’ level of beta amyloid protein plaques, revealing frustrations with the lack of information given.
Journal Watch columnist David Howett reviews the recent paper ‘Complement biomarkers as predictors of disease progression in Alzheimer’s disease’ and what its findings could mean for the future of Alzheimer’s disease diagnostics.
In an early stage clinical trial, scientists have demonstrated that the new antibody drug, Aducanumab, clears beta-amyloid plaques and slows cognitive decline in Alzheimer’s patients.
Researchers at the University of Cambridge (UK) have uncovered new information about the mechanism underlying the build up of amyloid plaques within the brains of Alzheimer’s disease patients.
Researchers demonstrate that amyloid precursor proteins may lead to endosome enlargement, contributing to early Alzheimer’s disease pathologies.
This exclusive opinion piece from Moir & Tanzi explores the arguments surrounding the ‘infection hypothesis’ of Alzheimer’s disease, inspired by Pisa et al’s recent controversial paper discussing fungal species in the Alzheimer’s brain.